Insider trades

Douglas Forsyth, Director of Inhibrx Biosciences INBX, has filed 2 purchases and 0 sales on the open market. The latest trade was on 06/03.

Douglas Forsyth

Director
First filing
23/05/30
Trades
12 trades
Buys / sales
2 / 0
12-month net buying
No record
Last trade
06/03

Trading activity

Transactions

Trade type
INBX
Open-market buy24/08/22–24/08/2324/08/2675,000 sh2 trades$13.83avg.$1,037,328.16+50.1%